No Data
No Data
European Equities Traded in the US as American Depositary Receipts Rise Friday
BioNTech Partial Clinical Hold an 'Incremental Negative,' Says Morgan Stanley
BioNTech Shares Slip as FDA Places Partial Clinical Hold on Lung Cancer Study
BioNTech's Cancer Trial Faces FDA Hold Challenges
BioNTech SE : FDA Has Placed Partial Clinical Hold on Two-stage, Open-label, Randomized Phase 3 Trial, PRESERVE-003
Novavax Stock Plummets 17% as FDA Pauses Clinical Trial on Safety Concerns -- Barrons.com
No Data
No Data